Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1177–1200 of 1,944 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Anxiety
Interventions: Dream Yoga Inspired Intervention, Sleep Health Enhancement program; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: Evanston, Illinois • Charlottesville, Virginia

Conditions: Breast Cancer
Interventions: trastuzumab, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, conventional surgery; Biological · Drug · Procedure
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 1 Year to 120 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2013
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Winston-Salem, North Carolina

Conditions: Alcohol Use Disorder
Interventions: CI-581a, CI-581b, MBRP, MET; Drug · Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 21 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Postural Tachycardia Syndrome, Autonomic Dysfunction, Postural Orthostatic Tachycardia Syndrome, POTS - Postural Orthostatic Tachycardia Syndrome
Interventions: GammaCore intervention, STEPS management protocol; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 19 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 2
States / cities: Rochester, Minnesota

Conditions: Palliative Care
Interventions: Meaning Centered Group Psychotherapy, Supportive Group Psychotherapy; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Substance Use Disorders
Interventions: Substance Use and Health Risk Intervention (SUHRI); Behavioral
Lead sponsor: Texas Christian University; Other
Eligibility: 14 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Melanoma
Interventions: Exercise Intervention, Wellness Intervention; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Smoking, Lung Cancer
Interventions: Telephone Counseling, Minimal Treatment; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 55 Years to 80 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Burlington, Massachusetts • Hackensack, New Jersey

Conditions: Effects of Chemotherapy, Aging, Frailty
Interventions: Geriatric Assessments and Frailty Indices; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
Interventions: Paclitaxel,, Bevacizumab, Cisplatin, Olaparib; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 5
States / cities: Basking Ridge, New Jersey • Commack, New York • Harrison, New York + 2 more

Conditions: Breast Cancer Female, Ovarian Cancer, Gastric Cancer
Interventions: Nivolumab, Ipilimumab; Biological
Lead sponsor: ExcellaBio LLC; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Human Immunodeficiency Virus, Human Immunodeficiency Virus Transmission, Sexually Transmitted Diseases
Interventions: Clinic-wide Trainings, Clinic-wide Trainings and HIV Prevention Decision Support Tool (DST); Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 45 Years
Enrollment: 141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Breast Cancer
Interventions: PF-07220060, letrozole; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 10
States / cities: Barrington, Illinois • Crystal Lake, Illinois • Park Ridge, Illinois + 2 more

Conditions: Autism Spectrum Disorder
Interventions: Project Search plus ASD Supports; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 21 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Chronic Pain, Chiari Malformation
Interventions: Online Acceptance and Commitment Therapy Intervention; Behavioral
Lead sponsor: Kent State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Kent, Ohio

Conditions: Interaction
Interventions: Oregano, Drug cocktail; Dietary Supplement · Drug
Lead sponsor: Washington State University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Foetal Exposure During Pregnancy
Interventions: Electronic SBI; Behavioral
Lead sponsor: Public Health Institute, California; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Oakland, California • Santa Rosa, California

Conditions: Schizophrenia
Interventions: Cognitive Enhancement Therapy, Social Skills Training; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders
Interventions: Community Reinforcement And Family Training, We The Village Peer Community Forum; Behavioral
Lead sponsor: We The Village, Inc.; Other
Eligibility: 19 Years and older
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Bilingualism, Vocabulary Acquisition, Late Talkers, Network Science
Interventions: Large Semantic Category Condition, Small Semantic Category Condition; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 24 Months to 30 Months
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prostate Cancer
Interventions: Radiation Therapy; Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Hypertension, Hemodialysis
Interventions: BP education and BP self-regulation, Supportive Educative Nursing Intervention; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Detroit, Michigan • Royal Oak, Michigan

Conditions: Depressive Disorder, Major
Interventions: Psilocybin, Niacin, Set and Setting (SaS) Protocol; Drug · Other
Lead sponsor: Usona Institute; Other
Eligibility: 21 Years to 65 Years
Enrollment: 347 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 11
States / cities: San Francisco, California • Santa Monica, California • New Haven, Connecticut + 8 more

Conditions: Heart Failure
Interventions: 6 Minute Walk Test Smart phone Application; Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Feasibility of a Mental-Health Intervention Based on Contemplative Sleep Practices

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)

Randomized Controlled Trial of Group Psychotherapy Interventions for Cancer Patients

The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth

3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma

Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening

Aging and Frailty Study

Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients

The OPENS Trial: Offering Women PrEP (Aim 2)

A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

Effect of a 9-Month Internship Intervention for Military Dependents With ASD

Online Acceptance and Commitment Therapy for Chronic Pain in Sample of People With Chiari Malformation

Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

Computerized Tool for Preventing Prenatal Drinking

What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia

Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones

Word Learning in Bilingual Typical and Late Talking Children: The Role of Meaning and Input

A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer

Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention

A Study of Psilocybin for Major Depressive Disorder (MDD)

Dynamic Heart Failure Prediction With Real-time Functional Status Data in the Ambulatory Setting